Treatment of peritoneal mesothelioma in pediatric patients

Pediatr Blood Cancer. 2009 Jan;52(1):127-9. doi: 10.1002/pbc.21718.

Abstract

Peritoneal mesothelioma is a rare and often aggressive malignancy, mostly affecting asbestos exposed adults. We present four pediatric peritoneal cases treated with a cisplatin-based doublet regimen, the standard of care in the systemic therapy of adult mesothelioma. Treatment was well tolerated, and three of these patients have achieved long-term survival. The fathers of three of the patients worked in the construction industry and may have been the source of indirect asbestos exposure.

MeSH terms

  • Adolescent
  • Asbestos
  • Cisplatin / therapeutic use
  • Disease-Free Survival
  • Female
  • Humans
  • Male
  • Mesothelioma / drug therapy*
  • Peritoneal Neoplasms / drug therapy*
  • Treatment Outcome
  • Young Adult

Substances

  • Asbestos
  • Cisplatin